4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000182
Director sold 10,111 shares at an average $73.51 ($743,238)
- Director acquired 10,111 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KLEIN JOSEPH III Director | 2026-05-01 | Option exercise 10b5-1 | +10,111 | $47.11 | $476,329 | 21,125 | D: show line 1 in the form |
| KLEIN JOSEPH III Director | 2026-05-01 | Sale 10b5-1 | −8,680 | $73.35 | $636,704 | 12,445 | D: show line 2 in the form |
| KLEIN JOSEPH III Director | 2026-05-01 | Sale 10b5-1 | −1,431 | $74.45 | $106,534 | 11,014 | D: show line 3 in the form |
| Open-market sales · 10,111 sh · avg $73.51 · $743,238 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KLEIN JOSEPH III Director | 2026-05-01 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −10,111 | 0 | D: show line 4 in the form |
Loading xslF345X06/edgardoc.xml…